How many 8-K filings has Interpace Biosciences, Inc. filed?

Interpace Biosciences, Inc. (IDXG) has 12 8-K (Current Event Report) filings on record, spanning Mar 2024 to Dec 2025.

What is a 8-K filing?

A 8-K is an SEC filing known as "Current Event Report." Filed to announce significant events or material changes such as acquisitions, executive departures, earnings announcements, or bankruptcy filings.

Where can I read Interpace Biosciences, Inc. 8-K filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Interpace Biosciences, Inc. 8-K filings, including risk assessment, sentiment analysis, and key financial figures.

Interpace Biosciences, Inc. (IDXG) — 8-K Filings

All 8-K filings from Interpace Biosciences, Inc.. Browse 12 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (12)

8-K Filing — Dec 3, 2025
INTERPACE BIOSCIENCES Files 8-K on Financials — Aug 8, 2025 Risk: low
On August 7, 2025, INTERPACE BIOSCIENCES, INC. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, a
INTERPACE BIOSCIENCES, INC. Files 8-K on Exit Costs — May 1, 2025 Risk: medium
On April 25, 2025, INTERPACE BIOSCIENCES, INC. filed an 8-K report detailing cost associated with exit or disposal activities and other events. The filing also
Interpace Biosciences Restates Financials — Mar 6, 2025 Risk: medium
On February 28, 2025, INTERPACE BIOSCIENCES, INC. announced that it will not rely on previously issued financial statements for the fiscal year ended December 3
INTERPACE BIOSCIENCES, INC. Files 8-K on Exit Costs — Jan 27, 2025 Risk: medium
On January 27, 2025, INTERPACE BIOSCIENCES, INC. filed an 8-K report detailing cost associated with exit or disposal activities, other events, and financial sta
INTERPACE BIOSCIENCES Enters Material Agreement, Faces Exit Costs — Jan 21, 2025 Risk: medium
On January 14, 2025, INTERPACE BIOSCIENCES, INC. entered into a material definitive agreement. This agreement also created a direct financial obligation or an o
INTERPACE BIOSCIENCES, INC. Files 8-K — Jan 10, 2025 Risk: low
On January 9, 2025, INTERPACE BIOSCIENCES, INC. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." No sp
INTERPACE BIOSCIENCES, INC. Files 8-K on Shareholder Vote Matters — Nov 13, 2024 Risk: medium
On November 12, 2024, INTERPACE BIOSCIENCES, INC. filed an 8-K report detailing a submission of matters to a vote of security holders. The filing indicates a sh
INTERPACE BIOSCIENCES FILES 8-K ON FINANCIALS — Nov 6, 2024 Risk: low
On November 4, 2024, INTERPACE BIOSCIENCES, INC. filed an 8-K report detailing events related to its financial condition and operations. The filing includes fin
INTERPACE BIOSCIENCES, INC. Files 8-K: Material Agreements & Equity Changes — Oct 15, 2024 Risk: medium
On October 10, 2024, INTERPACE BIOSCIENCES, INC. entered into a material definitive agreement. The company also reported on unregistered sales of equity securit
INTERPACE BIOSCIENCES, INC. Files 8-K on Financials — Aug 2, 2024 Risk: low
On August 1, 2024, INTERPACE BIOSCIENCES, INC. filed an 8-K report detailing results of operations and financial condition. The filing also includes financial s
INTERPACE BIOSCIENCES Files 8-K on Financials — Mar 13, 2024 Risk: low
On March 7, 2024, INTERPACE BIOSCIENCES, INC. filed an 8-K report detailing results of operations and financial condition. The filing includes financial stateme

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX